Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uncomplicated Plasmodium Falciparum”

Showing 20 of 0 results

Not applicableStudy completedNCT01326754
What this trial is testing

Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi

Who this might be right for
Malaria, Falciparum
Centers for Disease Control and Prevention 498
Post-approval studies (Phase 4)Study completedNCT00301015
What this trial is testing

Rapid Diagnostic Testing and Artemisinin-Based Combination Therapy for Uncomplicated Malaria by Community Health Workers

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Karolinska University Hospital 3,005
Testing effectiveness (Phase 2)Ended earlyNCT01442168
What this trial is testing

Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria

Who this might be right for
Malaria, Falciparum
Modus Therapeutics AB 53
Not applicableStudy completedNCT00461578
What this trial is testing

Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 800
Large-scale testing (Phase 3)Study completedNCT02083380
What this trial is testing

Phase II Efficacy Study of Artefenomel & Piperaquine in Adults & Children With P. Falciparum Malaria.

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Medicines for Malaria Venture 448
Testing effectiveness (Phase 2)Study completedNCT01594931
What this trial is testing

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Medicines for Malaria Venture 477
Not applicableStudy completedNCT00951106
What this trial is testing

Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon

Who this might be right for
Malaria, VivaxMalaria, Falciparum
Walter Reed Army Institute of Research (WRAIR)
Testing effectiveness (Phase 2)Ended earlyNCT02880241
What this trial is testing

MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

Who this might be right for
Malaria
Medicines for Malaria Venture 8
Testing effectiveness (Phase 2)Study completedNCT00459615
What this trial is testing

Phase II Dose Ranging Study of Artesunate

Who this might be right for
Falciparum MalariaUncomplicated Malaria
U.S. Army Office of the Surgeon General 120
Post-approval studies (Phase 4)Study completedNCT00699920
What this trial is testing

Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria Attacks

Who this might be right for
Malaria
Sanofi 413
Testing effectiveness (Phase 2)Looking for participantsNCT05750628
What this trial is testing

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Uncomplicated Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 327
Post-approval studies (Phase 4)UnknownNCT01075945
What this trial is testing

Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan

Who this might be right for
Malaria
University of Khartoum 140
Testing effectiveness (Phase 2)Study completedNCT01860989
What this trial is testing

Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

Who this might be right for
Cure Rate
Novartis Pharmaceuticals 11
Large-scale testing (Phase 3)Study completedNCT03923725
What this trial is testing

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.

Who this might be right for
Plasmodium Falciparum Malaria (Uncomplicated)
University of Oxford 2,583
Post-approval studies (Phase 4)Study completedNCT04767191
What this trial is testing

Malaria Therapeutic Efficacy Study (TES) Kenya

Who this might be right for
Uncomplicated Malaria
Jhpiego 400
Not applicableStudy completedNCT01052584
What this trial is testing

Ethiopia Malaria Therapeutic Efficacy Study

Who this might be right for
Malaria
Centers for Disease Control and Prevention 354
Large-scale testing (Phase 3)Study completedNCT01365598
What this trial is testing

Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in Uganda

Who this might be right for
Falciparum Malaria
London School of Hygiene and Tropical Medicine 468
Testing effectiveness (Phase 2)Ended earlyNCT00988507
What this trial is testing

Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Infection
Sanofi 440
Testing effectiveness (Phase 2)WithdrawnNCT01002183
What this trial is testing

Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate

Who this might be right for
Malaria
Jomaa Pharma GmbH 40
Early research (Phase 1)Study completedNCT02614404
What this trial is testing

Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
HuLow 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation